128 related articles for article (PubMed ID: 9681076)
1. No evidence of WT1 involvement in a Burkitt's lymphoma in a patient with Denys-Drash syndrome.
Perotti D; Mondini P; Giardini R; Ferrari A; Massimino M; Gambirasio F; Pierotti MA; Fossati-Bellani F; Radice P
Ann Oncol; 1998 Jun; 9(6):627-31. PubMed ID: 9681076
[TBL] [Abstract][Full Text] [Related]
2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
3. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
4. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
5. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
6. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
[TBL] [Abstract][Full Text] [Related]
7. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
Machin GA
Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
[No Abstract] [Full Text] [Related]
8. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
9. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.
Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V
Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
11. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
[TBL] [Abstract][Full Text] [Related]
14. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
Tsuda M; Sakiyama T; Owada M; Chiba Y
Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
[TBL] [Abstract][Full Text] [Related]
15. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
[TBL] [Abstract][Full Text] [Related]
16. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome.
Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614
[TBL] [Abstract][Full Text] [Related]
17. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
18. Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development.
Hastie ND
Hum Mol Genet; 1992 Aug; 1(5):293-5. PubMed ID: 1338905
[No Abstract] [Full Text] [Related]
19. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene.
Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI
Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061
[TBL] [Abstract][Full Text] [Related]
20. Inherited WT1 mutation in Denys-Drash syndrome.
Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
